MetaCap

Apimeds Pharmaceuticals US Statistics

NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.60-0.14 (-8.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Apimeds Pharmaceuticals US by the numbers

Apimeds Pharmaceuticals US has a market capitalization of $3.0 million based on 1.85M shares outstanding. With trailing EPS of $-12.69, Apimeds Pharmaceuticals US is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.9% below its 50-day average and 83.6% below its 200-day average.

Average daily trading volume is 3.73M shares, or about $6.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

APUS valuation vs. peer median

APUS compared with the median of 8 peer companies
MetricAPUSPeer medianDifference
Market cap$2.96M$3.12M-5%
Avg. volume3.73M363.29K+926%

Peer median across 8 companies: JAGX, SKYE, GELS, AZTR, MDCX, KPRX, NRSN, TRAW.

Valuation

Price and trading

Previous close
1.74
Open
1.77
Day range
1.51 – 1.77
52-week range
1.51 – 59.70
52-week change
-92.98%
Beta
—
Volume
48.55K

Dividends and events

Additional statistics

Market Cap
2.96M
Eps
-12.69
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
59.70
Week52 Low
1.51
Avg Volume
3.73M
Shares Outstanding
1.85M
Ma50
3.39
Ma200
9.73
Pct From52w High
-97.32%
Pct From52w Low
5.96%

Related